| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/13/1993 | EP0522078A1 Gp75 as a tumor vaccine for melanoma |
| 01/13/1993 | EP0522070A1 MOLECULAR CLONING OF THE GENES RESPONSIBLE FOR COLLAGENASE PRODUCTION FROM $i(CLOSTRIDIUM HISTOLYTICUM) |
| 01/13/1993 | EP0522054A1 Insect retinoid receptor compositions and methods |
| 01/13/1993 | EP0522018A1 CLONED $i(Kpn)I RESTRICTION-MODIFICATION SYSTEM |
| 01/13/1993 | EP0521996A1 Catalytic antibody components |
| 01/13/1993 | EP0521948A1 -g(g)-CGTase. |
| 01/13/1993 | EP0521915A1 Plant promoter |
| 01/13/1993 | EP0521910A1 Plant promoter |
| 01/13/1993 | EP0521909A1 Fetal cell recovery method |
| 01/13/1993 | EP0521873A1 Anticoagulant proteins |
| 01/13/1993 | EP0233937B1 Fermentation methods for hepatitis vaccine production |
| 01/13/1993 | EP0216833B1 Novel insulin derivatives and pharmaceutical preparations containing these derivatives |
| 01/13/1993 | CN1067778A Method and apparatus for inducing controlled stressed behavior in animals,(such as enhanced eating, drinking, mating, maternal or like behavior ) |
| 01/13/1993 | CA2073591A1 Method for detecting candida infection |
| 01/13/1993 | CA2073588A1 Coccidiosis vaccines |
| 01/12/1993 | US5179198 Glycoprotein and gene coding therefor |
| 01/12/1993 | US5179196 Purification of proteins employing ctap-iii fusions |
| 01/12/1993 | US5179078 Method of suppressing tumor formation in vivo |
| 01/12/1993 | US5179023 Genetic engineering |
| 01/12/1993 | US5179019 Therapeutic murine monoclonal antibody |
| 01/12/1993 | US5179018 Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria |
| 01/12/1993 | US5179017 Genetic engineering |
| 01/12/1993 | US5179015 Transformation; protecting host from digestion by presence of methyl transferase; genetic engineering |
| 01/12/1993 | US5179011 Process for producing biotin vitamers using novel microorganisms |
| 01/12/1993 | US5179007 From eukaryotic cells using a recombinant expression system |
| 01/12/1993 | US5179003 Process for the production of proteins or protein-containing gene products |
| 01/12/1993 | US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes |
| 01/12/1993 | US5178737 Electrophoretic resolution of single strand DNA by asymmetric field inversion |
| 01/12/1993 | CA1312567C Yeast strains with reduced intracellular atp levels |
| 01/12/1993 | CA1312565C Molecular probes for dna specific for the male genome of ruminants, especially of the subfamily of the bovines and particularly of the genus bos, the process for their preparationand the use of these probes for determining the sex of ruminant embryos and fetuses and for checking the presence of the y chromosome |
| 01/11/1993 | CA2073499A1 Inhibitors of hiv protease useful for the treatment of aids |
| 01/10/1993 | WO1993001312A1 Cartridge, device and method for preparing purified nucleic acids from a cell sample |
| 01/10/1993 | WO1993000907A1 Use of a 2-deoxystreptamine-type antibiotic |
| 01/10/1993 | CA2091264A1 Use of a 2-deoxystreptamine-type antibiotic |
| 01/10/1993 | CA2090409A1 Cartridge, device and method for preparing purified nucleic acids from a cell sample |
| 01/10/1993 | CA2073373A1 Bacillus strain and insect pest controlling agent |
| 01/09/1993 | CA2073412A1 Selection-gene-free transgenic plants |
| 01/09/1993 | CA2073378A1 Trkc protein |
| 01/07/1993 | WO1993000447A1 Amplification of target nucleic acids using gap filling ligase chain reaction |
| 01/07/1993 | WO1993000446A1 Screening assay for the detection of dna-binding molecules |
| 01/07/1993 | WO1993000438A1 AMPLIFIER AND SILENCER SEQUENCES ISOLATED FROM THE GPIIb PROMOTER |
| 01/07/1993 | WO1993000437A1 Cloning and/or expression vectors, preparation and use |
| 01/07/1993 | WO1993000436A1 Papillomavirus l2 protein |
| 01/07/1993 | WO1993000435A1 Adn sequences of the human papillomavirus type 42, and diagnostic application thereof |
| 01/07/1993 | WO1993000434A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | WO1993000433A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | WO1993000432A1 Bmp-9 compositions |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000430A1 Nucleotide sequences hybridizable with the nov gene of chickens |
| 01/07/1993 | WO1993000426A1 Mammalian pancreatic lipase and variant thereof |
| 01/07/1993 | WO1993000425A1 A novel receptor-type tyrosine kinase and use thereof |
| 01/07/1993 | WO1993000365A2 Hepatitis c virus (hcv) polypeptides |
| 01/07/1993 | WO1993000363A1 Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
| 01/07/1993 | WO1993000360A1 Methods and means for studying genetic polymorphism in the angiotensin converting enzyme |
| 01/07/1993 | WO1993000353A1 Sequences characteristic of human gene transcription product |
| 01/07/1993 | WO1993000352A1 Sequence-specific binding polymers for duplex nucleic acids |
| 01/07/1993 | WO1993000349A1 Totipotent hematopoietic stem cell receptors and their ligands |
| 01/07/1993 | WO1993000111A1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 01/07/1993 | WO1993000103A1 Chimeric envelope proteins for viral targeting |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000049A1 Osteogenic factor |
| 01/07/1993 | EP0521842A2 Tumor antigen specific antibody |
| 01/07/1993 | EP0521767A1 Production process of recombinant proteins and used host cells |
| 01/07/1993 | EP0521674A1 In vitro maturation of denuded bovine oocytes |
| 01/07/1993 | EP0521621A2 Modification of starch production |
| 01/07/1993 | EP0521586A1 FSH and other recombinant hormones |
| 01/07/1993 | EP0521427A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 01/07/1993 | EP0521348A1 Chimeric antibody with specificity for hepatitis B virus pre-S2 surface antigen and cell line producing same |
| 01/07/1993 | EP0521318A2 Hepatitis C diagnostics and vaccines |
| 01/07/1993 | EP0521240A2 Novel bacteriocin from lactococcus lactis subspecies lactis |
| 01/07/1993 | EP0521220A1 Recombinant immunogenic actinomycetale |
| 01/07/1993 | EP0521156A1 Dna coding for granulocytic colony stimulating factor receptor |
| 01/07/1993 | EP0521111A1 Polynucleotide capture assay employing in vitro amplification |
| 01/07/1993 | EP0521108A1 Site specific cleavage of single-stranded dna |
| 01/07/1993 | EP0506830A4 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
| 01/07/1993 | EP0484440A4 Efficient directional genetic cloning system |
| 01/07/1993 | EP0308499B1 Substrate assisted catalysis |
| 01/07/1993 | DE4122402A1 Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit Use of interleukin 10 for the manufacture of medicaments having tumor-inhibiting efficacy |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112492A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112226A1 Purification of recombinant apolipoprotein e from bacteria |
| 01/07/1993 | CA2111953A1 Methods and means for studying genetic polymorphism in the angiotensin converting enzyme i |
| 01/07/1993 | CA2111683A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | CA2093790A1 Osteogenic factor |
| 01/06/1993 | CN1067680A Hepatitis b virus surface proteins with reduced host carbohydrate content |
| 01/06/1993 | CN1067679A Recombinant dha-derived cholera toxin subunit analogs |
| 01/06/1993 | CA2073085A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening inhibitors of human cytomegalovirus |
| 01/05/1993 | US5177308 Genetic engineering |
| 01/05/1993 | US5177307 Compositions and methods for modulation of endogenous cytokinin levels |
| 01/05/1993 | US5177198 Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
| 01/05/1993 | US5177197 Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein |
| 01/05/1993 | US5177193 In vivo half-life, genetic engineering |
| 01/05/1993 | US5177017 Molecular cloning of the genes responsible for collagenase production from Clostridium histolyticum |
| 01/05/1993 | US5177016 Monoclonal antibody recognizing anthracycline glycoside specific epitope and hybridoma secerning the antibody |
| 01/05/1993 | US5177011 Plant elongation factor promoters, coding sequences and uses |
| 01/05/1993 | US5177010 Process for transforming corn and the products thereof |
| 01/05/1993 | US5176996 Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| 01/05/1993 | US5176995 Detection of viruses by amplification and hybridization |
| 01/05/1993 | CA1312298C Modifying cell metabolism via extra-cellular nucleases |